Skip to main content
OpenTrials

Clinical trial condition

Epidermolysis Bullosa Simplex

Explore clinical trials studying Epidermolysis Bullosa Simplex. Study availability and eligibility vary by location and protocol.

9 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Epidermolysis Bullosa Simplex trial results

Completed

INM-755 (Cannabinol) Cream for Treatment of Epidermolysis Bullosa

NCT04908215

Conditions
Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +13 more
Locations
  • Hopital Saint Louis APHP Paris Paris, France
  • CHU Toulouse - Hopital Larrey Toulouse, France
  • Universitaetsklinikum Freiburg Freiburg im Breisgau, Germany
  • Andreas Syggros Hospital of Cutaneous Venereal Diseases Athens, Greece
View Trial Details
Completed

Long Term Open-label Study Evaluating Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex

NCT03389308

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Epidermolysis Bullosa, +7 more
Locations
  • Ann and Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • University of North Carolina (UNC) - Chapel Hill Chapel Hill, North Carolina, United States
  • Children's Hospital of San Antonio San Antonio, Texas, United States
View Trial Details
Completed

To Evaluate the Pharmacokinetic of Diacerein and Rhein After Maximum Use in Patients With Epidermolysis Bullosa (EB)

NCT03472287

Conditions
Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • Stanford School of Medicine Palo Alto, California, United States
  • Northwestern University Medical Center Chicago, Illinois, United States
  • UNC Dermatology Chapel Hill, North Carolina, United States
View Trial Details

Related conditions